Correlation Between Akums Drugs and Spandana Sphoorty
Specify exactly 2 symbols:
By analyzing existing cross correlation between Akums Drugs and and Spandana Sphoorty Financial, you can compare the effects of market volatilities on Akums Drugs and Spandana Sphoorty and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akums Drugs with a short position of Spandana Sphoorty. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akums Drugs and Spandana Sphoorty.
Diversification Opportunities for Akums Drugs and Spandana Sphoorty
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akums and Spandana is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and Spandana Sphoorty Financial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spandana Sphoorty and Akums Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akums Drugs and are associated (or correlated) with Spandana Sphoorty. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spandana Sphoorty has no effect on the direction of Akums Drugs i.e., Akums Drugs and Spandana Sphoorty go up and down completely randomly.
Pair Corralation between Akums Drugs and Spandana Sphoorty
Assuming the 90 days trading horizon Akums Drugs is expected to generate 11.89 times less return on investment than Spandana Sphoorty. But when comparing it to its historical volatility, Akums Drugs and is 2.14 times less risky than Spandana Sphoorty. It trades about 0.03 of its potential returns per unit of risk. Spandana Sphoorty Financial is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 38,475 in Spandana Sphoorty Financial on October 12, 2024 and sell it today you would earn a total of 6,610 from holding Spandana Sphoorty Financial or generate 17.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Akums Drugs and vs. Spandana Sphoorty Financial
Performance |
Timeline |
Akums Drugs |
Spandana Sphoorty |
Akums Drugs and Spandana Sphoorty Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akums Drugs and Spandana Sphoorty
The main advantage of trading using opposite Akums Drugs and Spandana Sphoorty positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akums Drugs position performs unexpectedly, Spandana Sphoorty can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spandana Sphoorty will offset losses from the drop in Spandana Sphoorty's long position.Akums Drugs vs. Nahar Industrial Enterprises | Akums Drugs vs. Reliance Home Finance | Akums Drugs vs. Shivalik Bimetal Controls | Akums Drugs vs. Tata Communications Limited |
Spandana Sphoorty vs. Total Transport Systems | Spandana Sphoorty vs. Cholamandalam Investment and | Spandana Sphoorty vs. POWERGRID Infrastructure Investment | Spandana Sphoorty vs. Pilani Investment and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |